Proceedings of the ISSWSH 2024 Annual Meeting
Results: 451 women responded to the survey. Of those women, 85 (29.9%) stated they used cannabis specifically to help with orgasm. Overall, 70% stated “it helped them orgasm”, 24.4% stated, “It helped a little” and 5.6% stated, “It did not help”. Smoke or Vape: 52.8% Yes, it helped78.7% It helped a little-17% It did not help-4.3% Edibles: 37.1% Yes, it helped-61%% It helped a little-33% It did not help- 6.1 % Local application to genitals: 6.7% Yes, it helped 66.7% It helped a little 33.3% It did not help- 0% Tinctures or lozenges: 3.4% Yes, it helped-66.7% It helped a little -33% It did not help- 0% Conclusions:
Theoretically, cannabis may facilitate postmenopause orgasm due to its known vasodilation and antiinflammatory properties. Studying the efficacy of cannabis for the relief of specific symptoms is challenging since pharmacology is complex and dictated by variables such as route of consumption, product strain, genetics, sex, age, medical comorbidities, medications, and concomitant use of estrogen. In addition, one cannot count on the same level of consistency with individual products as with a commercial pharmaceutical. The perception of relief of symptoms is high, however, the impact of a placebo effect and the actual efficacy of individual practices cannot be determined given the above variables. The majority of women in the survey used edibles or inhalation, which may not be the most efficacious route of consumption to facilitate clitoral sensitivity. A larger population of women using direct application of cannabis to the clitoris would be useful. This study confirms the wide use of cannabis use in the menopause population specifically to facilitate orgasm and is useful in not only understanding current practices but will also inform the design of future studies. Disclosure: Any of the authors act as a consultant, employee or shareholder of an industry for: Sermonix.
Abstract citation ID: qdae054.020
(020) USE AND PERCEIVED IMPACT OF CANNABIS ON ORGASM IN POST MENOPAUSE WOMEN
L. Streicher1
1Northwestern University
Introduction: 55% of post-menopause women experience orgasmic dysfunction as a result of aging, vasculopathy, neuropathy, medications, and medical comorbidities. Orgasmic dysfunction can also be a downstream consequence of dyspareunia, genitourinary syndrome of menopause, hypoactive sexual desire disorder, and symptoms of menopause such as vasomotor symptoms and insomnia. There are no FDAapproved treatments for the treatment of FOD. At least one in four post-menopause women use cannabis, however, the frequency, route of consumption, and perceived efficacy of cannabis to facilitate orgasm in this population has not been studied.
Objective: To determine the frequency, route of consumption, and perceived efficacy use of cannabis to facilitate orgasm in a peri and post-menopause population. Methods: Women self-described as peri- or post-menopause, who currently or had recently used cannabis for relief of specific menopause symptoms, were recruited via social media and invited to complete an online survey. For each symptom, respondents were asked about the route(s) of consumption, and the perception of efficacy
